Active, Not Recruiting
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
NCT06189638
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +13 more
- Locations
-
- ILD Research Center Vista, California, United States
- Bioresearch Partner Holdings, LLLP Miami, Florida, United States
- Santos Research Center, Corp Tampa, Florida, United States